Hsbc Holdings PLC Sangamo Therapeutics, Inc Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

A detailed history of Hsbc Holdings PLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 20,120 shares of SGMO stock, worth $7,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,120

Previous 56,964 64.68%

Holding current value

$7,243

Previous $30,000 56.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $15,474 - $50,844	-36,844 Reduced 64.68%	20,120 $13,000
Q4 2023 Feb 12, 2024	BUY	$0.3 - $0.63 $126 - $264	420 Added 0.74%	56,964 $30,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $7,050 - $15,586	4,247 Added 8.12%	56,544 $99,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $30,141 - $45,107	7,059 Added 15.6%	52,297 $262,000
Q2 2022 Aug 11, 2022	BUY	$3.28 - $6.21 $96,182 - $182,102	29,324 Added 184.27%	45,238 $187,000

Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $83,230 - $124,447	15,914 New	15,914 $94,000
Q4 2021 Feb 11, 2022	SELL	$7.29 - $10.97 $161,531 - $243,073	-22,158 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $199,643 - $266,117	22,158 New	22,158 $202,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $120,071 - $188,163	-11,036 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $101,862 - $200,634	11,036 New	11,036 $172,000
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $413,526 - $550,193	-44,086 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $74,818 - $142,527	12,048 Added 37.61%	44,086 $395,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $161,791 - $283,536	32,038 New	32,038 $199,000
Q2 2019 Aug 13, 2019	SELL	$8.75 - $13.03 $266,875 - $397,415	-30,500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $270,261 - $448,452	-35,008 Reduced 53.44%	30,500 $291,000
Q4 2018 Feb 13, 2019	BUY	$9.51 - $16.6 $622,981 - $1.09 Million	65,508 New	65,508 $752,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Sangamo Therapeutics, Inc Transaction History